Team:DTU-Denmark/Team2
From 2010.igem.org
(One intermediate revision not shown) | |||
Line 148: | Line 148: | ||
</tr> | </tr> | ||
</table> | </table> | ||
- | </ | + | <table cellpadding=10px> |
- | </ | + | <tr> |
- | + | <td width="163px" height="100%" valign="top"> | |
- | In synthetic biology when creating the minimal cell XXX factors have been identified as essential for normal function of RNAP, both regarding normal elongation but also in terms of normal termination function. (REFFF) of these XXX have been identified to take part in regulatory function. While the rest is core subunits. Of interest for regulation in terms of termination Anti-termination will be highlighted:</p> | + | <font color="#990000" face="arial" size="3"> |
+ | <ul type="circle"> | ||
+ | <li><a href="https://2010.igem.org/Team:DTU-Denmark/Basics">Basics</a></li><br> | ||
+ | <li><a href="https://2010.igem.org/Team:DTU-Denmark/Regulatory_sytems">Regulatory Systems</a></li><br> | ||
+ | <li><a href="https://2010.igem.org/Team:DTU-Denmark/Switch">The Switch</a></li><br> | ||
+ | <li><a href="https://2010.igem.org/Team:DTU-Denmark/SPL">Synthetic Promoter Library</a></li><br> | ||
+ | <li><a href="https://2010.igem.org/Team:DTU-Denmark/Team1">Anti-Repressor group</a></li><br> | ||
+ | <li ><a href="https://2010.igem.org/Team:DTU-Denmark/Team2">Anti-Terminator group</a></li><br> | ||
+ | <li ><a href="https://2010.igem.org/Team:DTU-Denmark/BBrick_Characterisation">Characterisation of Biobricks</a></li><br> | ||
+ | </ul> | ||
+ | </td> | ||
+ | <td> | ||
+ | <font color="#333333" face="arial" size="2.5"> | ||
+ | <td width="570 px"> | ||
+ | <h1>Introduction</h1> | ||
+ | <p align="justify">In synthetic biology when creating the minimal cell XXX factors have been identified as essential for normal function of RNAP, both regarding normal elongation but also in terms of normal termination function. (REFFF) of these XXX have been identified to take part in regulatory function. While the rest is core subunits. Of interest for regulation in terms of termination Anti-termination will be highlighted:</p> | ||
<ul> | <ul> | ||
<li>NusA:</li> | <li>NusA:</li> | ||
Line 160: | Line 175: | ||
<p align="justify">Due to the construction of the RNAP of many subcomponents and systems, the function of the RNAP can be regulated by only adding or changing one or a few factors. This is the mechanism in the different termination and anti-termination functions described below.</p><br> | <p align="justify">Due to the construction of the RNAP of many subcomponents and systems, the function of the RNAP can be regulated by only adding or changing one or a few factors. This is the mechanism in the different termination and anti-termination functions described below.</p><br> | ||
<p align="justify">Figure and table containing normal transcription and normal termination and table with sub-part names and explanation.</p><br> | <p align="justify">Figure and table containing normal transcription and normal termination and table with sub-part names and explanation.</p><br> | ||
+ | </td> | ||
+ | <td width="163px" height="100%" valign="top"> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </font> | ||
+ | </table> | ||
+ | |||
+ | </body> | ||
+ | </html> |
Latest revision as of 10:56, 12 October 2010
Home | The Team | The Project | Parts submitted | Modelling | Notebook | Blog |
IntroductionIn synthetic biology when creating the minimal cell XXX factors have been identified as essential for normal function of RNAP, both regarding normal elongation but also in terms of normal termination function. (REFFF) of these XXX have been identified to take part in regulatory function. While the rest is core subunits. Of interest for regulation in terms of termination Anti-termination will be highlighted:
Due to the construction of the RNAP of many subcomponents and systems, the function of the RNAP can be regulated by only adding or changing one or a few factors. This is the mechanism in the different termination and anti-termination functions described below. Figure and table containing normal transcription and normal termination and table with sub-part names and explanation. |